Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00434395 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
A Phase 1 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00434395: Completed Phase 1 study, sponsored by Bausch Health Americas.
NCT00434395 is a Phase 1 study that has completed, run by Bausch Health Americas. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00434395, a Phase 1 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
Interventions
- DRUG MOA-728
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00434395 record still lists
NCT00434395 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which MOA-728 is the first listed.
NCT00434395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00434395 about?
NCT00434395 is a clinical study titled "Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects". The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
What is the current status of trial NCT00434395?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00434395?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00434395?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia